| Literature DB >> 29669945 |
Yoshinari Obata1, Shunbun Kita1,2, Yoshihisa Koyama3, Shiro Fukuda1, Hiroaki Takeda4, Masatomo Takahashi4, Yuya Fujishima1, Hirofumi Nagao1, Shigeki Masuda1, Yoshimitsu Tanaka1, Yuto Nakamura1, Hitoshi Nishizawa1, Tohru Funahashi1,5, Barbara Ranscht6, Yoshihiro Izumi4, Takeshi Bamba4, Eiichiro Fukusaki7, Rikinari Hanayama8, Shoichi Shimada3, Norikazu Maeda1,5, Iichiro Shimomura1.
Abstract
Adiponectin, an adipocyte-derived circulating protein, accumulates in vasculature, heart, and skeletal muscles through interaction with a unique glycosylphosphatidylinositol-anchored cadherin, T-cadherin. Recent studies have demonstrated that such accumulation is essential for adiponectin-mediated cardiovascular protection. Here, we demonstrate that the adiponectin/T-cadherin system enhances exosome biogenesis and secretion, leading to the decrease of cellular ceramides. Adiponectin accumulated inside multivesicular bodies, the site of exosome generation, in cultured cells and in vivo aorta, and also in exosomes in conditioned media and in blood, together with T-cadherin. The systemic level of exosomes in blood was significantly affected by adiponectin or T-cadherin in vivo. Adiponectin increased exosome biogenesis from the cells, dependently on T-cadherin, but not on AdipoR1 or AdipoR2. Such enhancement of exosome release accompanied the reduction of cellular ceramides through ceramide efflux in exosomes. Consistently, the ceramide reduction by adiponectin was found in aortas of WT mice treated with angiotensin II, but not in T-cadherin-knockout mice. Our findings provide insights into adiponectin/T-cadherin-mediated organ protection through exosome biogenesis and secretion.Entities:
Keywords: Adipose tissue; Cardiovascular disease; Cell Biology; Metabolism; endothelial cells
Mesh:
Substances:
Year: 2018 PMID: 29669945 PMCID: PMC5931116 DOI: 10.1172/jci.insight.99680
Source DB: PubMed Journal: JCI Insight ISSN: 2379-3708